Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Correvio Pharma Corp. CORV

Healthcare Drug Manufacturers - Major
Correvio Pharma Corp is specialty pharmaceutical company. It offers patients and healthcare providers therapeutic solutions for acute medical conditions to improve health and quality of life. Its products are Aggrastat, Esmocard, Brinavess, Xydalba, Zevtera/Mabelio, and others. It offers solutions on Acute Bacterial Skin and Skin Structure Infections, Acute Coronary Syndromes, Atrial... see more

Bullboard (NDAQ:CORV)

View:
Prev 1 2 3 Next
Comment by bigkaganon Dec 12, 2019 3:43pm

RE:why it is very risky to invest?

they still have Trevyent approval pending in April and Brinavess could be allowed under the Right-To-Try Act in the US
106
Discussion
Post by mingzhuon Dec 12, 2019 2:00pm

why it is very risky to invest?

1, $44 m USD  debt 2, cash run out by the middle of 2020 3, debt to capital ratio 2:1 such stock is only good for a trade not invetment. 
199
Discussion
Comment by bigkaganon Dec 12, 2019 12:09pm

RE:it's a buy today for me

CORV is a little scavenger which picks up drugs that have been dumped by big pharma because they couldn't sell them
119
Discussion
Post by coolfooldumbguyon Dec 12, 2019 11:00am

it's a buy today for me

at .395 cents U.S. per share,it is oversold to me,so glta shareholders,but this one should rebound to the upside.
132
Discussion
Comment by bigkaganon Dec 12, 2019 10:47am

RE:RE:It will bounce back

FDA could approve Brinavess with some warnings, given the Right-to-try law in the US they can't deny those willing to try the drug as an alternative if other drugs don't help them, especially ...more  
115
Discussion
Comment by SmellsFishyon Dec 12, 2019 10:01am

RE:It will bounce back

I speculated before the HALT and got burned.  I dumped yesterday after reading the notes in their financials.  The ASSETS of the company have been given as collateral to the debt ...more  
140
Discussion
Comment by bigkaganon Dec 12, 2019 9:59am

RE:It will bounce back

man, I didn't know that their whole SP was hinging on the Brinavess approval, but if it's not being used in Europe even though it's allowed there why would they use it in the US even if ...more  
118
Discussion
Post by goforit59on Dec 11, 2019 6:01pm

It will bounce back

https://money.cnn.com/quote/forecast/forecast.html?symb=CORV
166
Discussion
Post by Wild519on Dec 11, 2019 9:52am

Soon it will be 10 cent

Sorry for all the people who got D at this time of the year from this shitty company.
84
Comment by bigkaganon Dec 10, 2019 10:01pm

RE:CORV Outcome

man, it's crazy - only 56 cents in the US, somebody should sue CORV for applying to FDA knowing it had no chance with Brinavess
73
Discussion
Comment by bigkaganon Dec 10, 2019 4:03pm

RE:FDA rejected it!!!

a year ago it was at $4 long before they resubmitted Brinavess to FDA, the drop is way overdone and we still have Trevyent in April
74
Discussion
Post by mingzhuon Dec 10, 2019 3:38pm

FDA rejected it!!!

it is going under $1 when it open.
90
Discussion
Comment by bigkaganon Dec 09, 2019 10:04am

RE:RE:Will test $1.65 Canadian

these probably were the guys who worked at FDA 10 years ago when it rejected Brinaess and they still remember the arguments. The advisory committee will have to consider that since then so many ...more  
120
Discussion
Comment by bigkaganon Dec 06, 2019 7:50pm

RE:Will test $1.65 Canadian

the reason for the sell-off was that some anonymous staffers at FDA badmouthed Brinavess as "too dangerous" but it still could be approved with some limitations when the experts meet on Dec ...more  
145
Discussion
Prev 1 2 3 Next